Affordable Access

deepdyve-link
Publisher Website

Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP).

Authors
  • Grimison, P S
  • Stockler, M R
  • Chatfield, M
  • Thomson, D B
  • Gebski, V
  • Friedlander, M
  • Boland, A L
  • Houghton, B
  • Gurney, H
  • Rosenthal, M
  • Singhal, N
  • Kichenadasse, G
  • Wong, S S
  • Lewis, C R
  • Vasey, P A
  • Toner, G C
Type
Published Article
Journal
Annals of Oncology
Publisher
Oxford University Press
Publication Date
Jan 01, 2014
Volume
25
Issue
1
Pages
143–148
Identifiers
DOI: 10.1093/annonc/mdt369
PMID: 24356625
Source
Medline
Keywords
License
Unknown

Abstract

Accelerated BEP is feasible and tolerable. Efficacy data appear to be promising. This trial and a similar UK study provide the rationale for a randomised trial comparing accelerated versus standard BEP. Australian New Zealand Clinical Trials Registry Registration number. ACTRN 12607000294459.

Report this publication

Statistics

Seen <100 times